Traders should monitor AEON's progress toward regaining compliance by August 3, 2026, as failure could lead to delisting and severely reduced liquidity. The recent S-3 filing in February 2026 suggests capital raising efforts, but the persistent deficit indicates ongoing financial distress.
Price Chart
Executive Summary
AEON Biopharma received an additional delisting notice from NYSE American due to a stockholders' deficit of approximately $55 million as of December 31, 2025, failing to meet the $4.0 million equity requirement under Section 1003(a)(ii) of the NYSE American Company Guide. The company remains on a compliance plan with a deadline of August 3, 2026, and its stock continues to trade with a .BC indicator denoting non-compliance.
Key Facts
- Received delisting notice from NYSE American on March 31, 2026, for non-compliance with Section 1003(a)(ii) requiring $4.0 million in stockholders' equity.
- Stockholders' deficit was approximately $55 million as of December 31, 2025.
- Company previously received a notice under Section 1003(a)(i) and submitted a compliance plan accepted by NYSE American on April 22, 2025, with a deadline of August 3, 2026.
- Stock continues to trade on NYSE American under the symbol AEON with a .BC indicator for non-compliance.
- Company has the right to appeal any future delisting determination.
Financial Impact
Stockholders' deficit of approximately $55 million as of December 31, 2025, significantly below the $4.0 million equity requirement.
Risk Factors
- Potential delisting if compliance is not achieved by August 3, 2026.
- Reduced institutional ownership and liquidity if delisted.
- Inability to raise sufficient capital to meet listing requirements.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001837607-26-000025 |
| Document: aeon-20260331xex99d1.htm | 0001837607-26-000025 |
| Document: 0001837607-26-000025-index-headers.html | 0001837607-26-000025 |
| Document: 0001837607-26-000025-index.html | 0001837607-26-000025 |
| Document: 0001837607-26-000025.txt | 0001837607-26-000025 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | 8-K | $0.2399 | awaiting T+5 | — | $0.2400 (+0.04%) |
Sep 30, 2026 26d ago | 8-K | $0.3000 $0.3110 | ▲ +3.67% | ▲ +1.75% | $0.2400 (−20.00%) |
Aug 21, 2026 9w ago | 3 | $0.1974 $0.2959 | ▲ +49.90% | ▲ +49.43% | $0.2400 (+21.58%) |
Aug 19, 2026 9w ago | Press Release | $0.1980 $0.2515 | ▲ +27.02% | ▲ +27.41% | $0.2400 (+21.21%) |
Aug 12, 2026 10w ago | Press Release | $0.2706 $0.1931 | ▼ −28.64% | ▼ −26.68% | $0.2400 (−11.31%) |
Jul 23, 2026 13w ago | 8-K | $0.2507 $0.2552 | ▼ −1.79% | ▼ −1.42% | $0.2400 (+4.27%) |
Jul 15, 2026 14w ago | 8-K | $0.2974 $0.2600 | ▲ +12.58% | ▲ +10.91% | $0.2400 (+19.30%) |
Jul 15, 2026 14w ago | 424B4 | $0.2997 $0.2752 | ▲ +8.17% | ▲ +7.19% | $0.2400 (+19.92%) |
Jul 14, 2026 14w ago | EFFECT | $0.3570 $0.2890 | ▲ +19.05% | ▲ +17.75% | $0.2400 (+32.77%) |
Jul 9, 2026 15w ago | S-1/A | $0.5027 $0.2974 | ▲ +40.84% | ▲ +40.71% | $0.2400 (+52.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers